,,ii  #aah? ,,congress  #b;d ,session   
,s4 #deaj  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,june #aa1 #bjbd,mrs4  
,blackburn 7= h]self & ,mr4 ,lujn7      
introduc$ ! foll[+ bill2 :i* 0 read     
twice & ref]r$ to ! ,committee on       
,f9ance  ,a ,,bill  ,to am5d ! ,am]ican 
,taxpay] ,relief ,act ( #bjab to delay  
implem5tation ( ! inclusion ( oral-only 
,,esrd-relat$ drugs 9 ! ,m$ic>e ,,esrd  
prospective paym5t sy/em4  #a4 ,%ort    
title ,?is ,act may be cit$ z ! ,kidney 
,pati5t ,access to ,te*nologically      
,innovative & ,ess5tial ,nephrology     
,treatm5ts ,act ( #bjbd or ! ,kidney    
,,pati5t ,act ( #bjbd4  #b4 ,prohibition
 ( implem5tation ( oral-only policy =   
c]ta9 drugs "u ,m$ic>e ,,esrd           
prospective paym5t sy/em  7a7 ,9 g5]al  
,section #fcb7;b7 ( ! ,am]ican ,taxpay] 
,relief ,act ( #bjab 7#db ,u4,s4,c4     
#acierr note7 is am5d$-- 7#a7 9 ! head+1
 by /rik+ ,two-ye> delay & ins]t+       
,delay2 &  7#b7 9 ! fir/ s5t5ce (       
p>agraph 7#a71 by /rik+ may n implem5t &

 all t foll[s ?r\gh ,janu>y #a1 #bjbe4 &
 ins]t+ may n implem5t ! policy "u      
section #dac4agd7;f77#f7 ( title #db1   
,code ( ,f$]al ,regulations 7relat+ to  
oral-only ,,esrd-relat$ drugs 9 ! ,,esrd
 prospective paym5t sy/em7 ) respect to 
su* drugs indicat$ = ! r$uction1        
managem5t1 or control ( ! s]um phosphate
 ( an individual be=e ,janu>y #a1       
#bjbg44  7b7 ,/udy ,n lat] ?an #a ye>   
aft] ! date ( ! enactm5t ( ?is ,act1 !  
,secret>y ( ,heal? & ,human ,s]vices    
%all submit to ,congress & make         
available on ! public website ( ! ,c5t]s
 = ,m$ic>e  ,m$icaid ,s]vices a report  
conta9+ data f #bjbb ?r\gh #bjbd on--   
7#a7 ! numb] ( individuals entitl$ to   
b5efits "u "p ,a ( title ,,xviii ( !    
,social ,security ,act 7#db ,u4,s4,c4   
#acie;c et seq47 or enroll$ "u "p ,b (  
su* title 7#db ,u4,s4,c4 #acie;j et     
seq47 ) end-/age r5al disease :o are    
enroll$ "u a prescription drug plan "u  
"p ,d ( su* title 7#db ,u4,s4,c4        
#aciew-#aja et seq47 or "u an ,,ma-,,pd 

plan "u "p ,c ( su* title 7#db ,u4,s4,c4
 #aciew-#ba et seq471 along ) a         
specification ( any gaps 9 cov]age "u   
su* prescription drug plans or ,,ma-,,pd
 plans2  7#b7 ! am\nt ( exp5ditures "u  
su* "p ,d attributable to oral-only     
drugs relat$ to ! treatm5t ( end-/age   
r5al disease & ! am\nt ( co/ %>+ incurr$
 by su* individuals = su* drugs2  7#c7  
su* individuals' adh]5ce to             
prescriptions = su* drugs1 includ+ z    
measur$ by s]um phosphate levels1       
report$ ?r\gh ! end-/age r5al disease   
quality report+ sy/em2  7#d7 adv]se     
ev5ts ( su* individuals relat$ to       
hyp]phosphatemia & e/imat$ co/s         
attributable to su* adv]se ev5ts "u su* 
title2 &  7#e7 any recomm5d$ /rategies  
or /&>ds ( practice to increase adh]5ce 
to prescrib$ phosphate b9d]s or l[]+    
ag5ts or o!r /rategies to r$uce co/s to 
su* individuals & exp5ditures "u su*    
program = su* ag5ts4